Company Metrics

• 19.95 P/E
• 1.69 P/S
• 1.5 P/B
• 2.003 EPS
• 10.43% Cash ROIC
• 0.08 Cash Ratio
• 1.136 / 2.84% Dividend
• 4.08M Avg. Vol.
• 852.00M Shares
• 34.276B Market Cap.

Company Description

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs in various therapeutic categories worldwide. It offers generic pharmaceutical products in a range of dosage forms, such as tablets, capsules, ointments, creams, liquids, injectables, and inhalants. The company also provides branded products, including Copaxone to treat multiple sclerosis; and Azilect to treat Parkinson's disease. Its principal branded respiratory products include ProAir a short-acting beta-agonist to treat bronchial spasms and exercise-induced bronchospasm; and Qvar, an inhaled corticosteroid for long-term control of chronic bronchial asthma, as well as Airomirin metered dose inhalers; and Easi-Breathe and Autohaler in breath-actuated inhalers. In addition, the company provides women's health products in various categories comprising oral contraceptives, intrauterine contraception, hormone therapy treatments for menopause/perimenopause, and therapies for use in infertility and urinary incontinence. Further, it offers biosimilar products, such as Granulocyte Colony Stimulating Factor (GCSF) that is used to reduce the risk of infections in oncology patients receiving chemotherapy; Eporatio, which is used for the treatment of renal anemia or chemotherapy-induced anemia; and Tev-Tropin, a human growth hormone indicated for the treatment of children. The company's biosimilar products also comprise Neugraninm and XM22, which are long-acting GCSFs and are in Phase III clinical development, as well as XM17 that is in Phase III clinical development for the treatment of female infertility. Additionally, it manufactures generic animal pharmaceuticals; and markets proprietary dermatological and nutraceutical veterinary products, as well as produces active pharmaceutical ingredients. It has strategic alliance agreements with Impax Laboratories, Inc.; and Alcobra Ltd. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
less

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs in various therapeutic categories worldwide. It offers generic pharmaceutical products in a range of dosage forms, such as tablets, capsules, ointments, creams, liquids, injectables, and inhalants. The company also provides branded products, including Copaxone to treat multiple sclerosis...
more

News